Peter Coleman
Chief Executive
medicine
Cobra Biologics
Sweden
Biography
Prior to his appointment as CEO in May 2011, Peter was Finance Director at Cobra and Recipharm Ltd, Ashton. Peter was also Finance Director of Cobra Biomanufacturing Plc up to its acquisition by Recipharm in 2010, and he has been at the Keele facility for more than nine years. Prior to Cobra he was employed in a number of senior financial and corporate development roles. Peter was awarded an MBA with distinction jointly from the Manchester Business School and the University of Wales.
Research Interest
medicine
